Reliance's Strand Life Sciences Secures Indian Patent
Reliance Industries' subsidiary Strand Life Sciences secured an Indian patent on July 7, 2026, for an AI-enabled blood test that detects early-stage cancer using cell-free DNA analysis. The platform c…